Intellectual Property Magazine
Method of treatment eligibility
Three cases in 2019 at the Federal Circuit have provided some clarity on the eligibility of method of treatment patents
Aziz Burgy, Christopher Gallo and Gabriella Mahan - Axinn
Recentcases from the US Court of Appeals for the Federal Circuit (CAFC) have further
clarified the patent eligibility of method of treatment patents under 35 USC §
101. In Vanda Pharmaceuticals Inc v West-Ward Pharmaceuticals International
Ltd,
1 the CAFC addressed patent eligibility of method of
treatment patents.